Background: Bronchiolitis obliterans organizing pneumonia (BOOP) may be classified as cryptogenic (idiopathic) and secondary. There are no clear clinical and radiological features distinguishing between idiopathic and secondary BOOP. Objectives: To analyze the etiologic factors, clinical and radiological features, diagnostic approach and response to therapy at onset and outcome in subjects with BOOP. Methods: The medical files of Erciyes University Hospital from 1995 to 2003 were retrospectively reviewed. Patients with biopsy-proven BOOP were selected for evaluation. The etiology and initial features of BOOP, treatment, resolution, relapse, and survival were obtained from medical records, and a follow-up patient questionnaire. Results: We have diagnosed 26 cases (13 males /13 females) with BOOP syndrome (mean age 54 ± 15 years, range 14–93). More than half the patients (58%) were classified as idiopathic BOOP. Patients presented with cough (92%), dyspnea (70%), pleuritic chest pain, hemoptysis and fever (50%). The biopsy specimens had been obtained by transbronchial and/or transthoracic lung biopsy in 18 cases (69%). At radiological evaluation, there were bilateral patchy alveolar and/or interstitial infiltrates in 16 patients (62%), and solitary pneumonic involvement in 10 patients (38%). Three patients recovered spontaneously, 5 remained cured after resection of the focal lesion. Corticosteroid therapy was given in 17 patients (65%). Apart from four patients who died (death was attributable to BOOP in only 1 patient) and three patients who relapsed, the prognosis was good in all patients. Conclusions: The etiology of BOOP is usually idiopathic. We observed that hemoptysis and pleuritic chest pain were a relatively frequent symptom in BOOP in the present series, in contrast to previous observations. The diversity of radiological and clinical presentations including hemotysis and pleuritic chest pain should prompt consideration of the diagnosis in patients with persisting pulmonary symptoms and radiological findings.

Keywords:
Bronchiolitis obliterans organizing pneumonia, Organizing pneumonia, Cryptogenic organizing pneumonia
1.
Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA: Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152–158.
2.
Colby TV: Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102:38S–43S.
3.
Epler GR: Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161:158–164.
4.
Cordier JF: Organizing pneumonia. Thorax 2000;55:318–328.
5.
Camus P, Fanton A, Bonniaud P, Camus C, Foucher P: Interstitial lung disease induced by drugs and radiation. Respiration 2004;71:301–326.
6.
Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF: Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d’Etudes et de Recherche sur les Maladies ‘Orphelines’ Pulmonaires (GERM’O’P). Am J Respir Crit Care Med 2000;162:571–577.
7.
Cohen AJ, King TE, Downey GP: Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149:1670–1675.
8.
Lohr RH, Boland BJ, Douglas WW, Dockrell DH, Colby TV, Swensen SJ, Wollan PC, Silverstein MD: Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997;157:1323–1329.
9.
Cazzato S, Zompatori M, Baruzzi G, Schiattone ML, Burzi M, Rossi A, Ratta L, Terzuolo G, Falcone F, Poletti V: Bronchiolitis obliterans with organizing pneumonia: An Italian experience. Respir Med 2000;94:702–708.
10.
Inoue T, Toyoshima K, Kikui M: Idiopathic bronchiolitis obliterans organizing pneumonia (idiopathic BOOP) in childhood. Pediatr Pulmonol 1996;22:67–72.
11.
Bellomo R, Finlay M, McLaughlin P: Clinical spectrum of cryptogenic organizing pneumonitis. Thorax 1991;46:554–558.
12.
Cordier JF, Loire R, Brune J: Idiopathic BOOP: definition of characteristic clinical profiles in a series of 16 patients. Chest 1989;96:999–1004.
13.
Alegre-Martin J, De Sevilla TF, Falco V, Martinez- Vazquez JM: Three cases of idiopathic BOOP. Eur Respir J 1991;4:901–902.
14.
Van Thiel RJ, Van der Burg S, Groote AD, Nossent GD, Wills SH: Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Eur Respir J 1991;4:905–911.
15.
Staud R, Ramos LG: Influenza A-associated bronchiolitis obliterans organizing pneumonia mimicking Wegener’s granulomatosis. Rheumatol Int 2001;20:125–128.
16.
Meerhaeghe AV, Sukkarieh F, Cornut P, Peché R, Bissen L, Brasseur P: Pulmonary nodular lesions in a 70-year-old man. Eur J Intern Med 2003;14:332–337.
17.
Murphy J, Schnyder P, Herold C, Flower C: Bronchiolitis obliterans organizing pneumonia simulating bronchial carcinoma. Eur Radiol 1998;8:1165–1169.
18.
Mroz BJ, Sexauer WP, Meade A, Balsara G: Hemoptysis as the presenting symptom in bronchiolitis obliterans organizing pneumonia. Chest 1997;111:1775–1778.
19.
Spiteri MA, Klernerman P, Sheppard MN, Padley S, Clark TJ, Newman-Taylor A: Seasonal cryptogenic organising pneumonia with biochemical cholestasis: A new clinical entity. Lancet 1992;340:281–284.
20.
Akira M, Yamamoto S, Sakatani M: Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR 1998;170:291–295.
21.
Zompatori M, Bna C, Poletti V, Spaggiari E, Ormitti F, Calabro E, Tognini G, Sverzellati N: Diagnostic imaging of diffuse infiltrative disease of the lung. Respiration 2004;71:4–19.
22.
Muller NL, Staples CA, Miller RR: Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR1990;154:983–987.
23.
Bouchardy LM, Kuhlman JE, Ball WC Jr, Hruban RH, Askin FB, Siegelman SS: CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993;17:352–357.
24.
Arakawa H, Krihara Y, Niimi H, Nakajima Y, Johkoh T, Nakamura H: Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: High-resolution CT findings in 81 patients. AJR 2001;176:1053–1058.
25.
Chandler PW, Shin MS, Friedman SE, Friedman SE, Katzenstein A-L: Radiographic manifestations of bronchiolitis obliterans with organizing pneumonia vs usual interstitial pneumonia. AJR 1986;147:899–906.
26.
Izumi T, Kitaichi M, Nishimura K, Nagai S: Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992;102:715–719.
27.
Mokhtari M, Bach PB, Tietjen PA, Stover DE: Bronchiolitis obliterans organizing pneumonia in cancer: A case series. Respir Med 2002;96:280–286.
28.
Chetta A, Marangio E, Olivieri D: Pulmonary function testing in interstitial lung diseases. Respiration 2004;71:209–213.
29.
Costabel U, Teschler H, Guzman J: Bronchiolitis obliterans organizing pneumonia (BOOP): The cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5:791–797.
30.
Poletti V, Castrilli G, Romagna M, Colaste A, Aiello FB, Baruzzi G, Musiani P: Bronchoalveolar lavage, histological and immunohistochemical features in cryptogenic organizing pneumonia. Monaldi Arch Chest Dis 1996;51:289–295.
31.
Bartter T, Irwin RS, Nash G, Balikian JP, Hollingsworth HH: Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram. Arch Intern Med 1989;149:273–279.
32.
Muller NL, Guerry-Force ML, Staples CA, Wright JL, Wiggs B, Coppin C, Pare P, Hogg JC: Differential diagnosis of BOOP and usual interstitial pneumonia: Clinical, functional, and radiologic findings. Radiology 1987;162:151–156.
33.
Watanabe K, Senju S, Wen FQ: Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998;114:1599–1606.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.